Free Trial

Janus Henderson Group PLC Has $424.95 Million Stock Holdings in Rentokil Initial plc (NYSE:RTO)

Rentokil Initial logo with Business Services background

Janus Henderson Group PLC lessened its stake in Rentokil Initial plc (NYSE:RTO - Free Report) by 1.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,782,804 shares of the company's stock after selling 207,375 shares during the period. Janus Henderson Group PLC owned 3.32% of Rentokil Initial worth $424,953,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Keystone Financial Services acquired a new position in Rentokil Initial during the fourth quarter worth about $236,000. ABS Direct Equity Fund LLC increased its holdings in shares of Rentokil Initial by 28.1% in the fourth quarter. ABS Direct Equity Fund LLC now owns 160,000 shares of the company's stock valued at $4,051,000 after buying an additional 35,100 shares in the last quarter. Stephens Inc. AR boosted its position in shares of Rentokil Initial by 6.1% in the 4th quarter. Stephens Inc. AR now owns 431,185 shares of the company's stock valued at $10,918,000 after purchasing an additional 24,699 shares during the period. Janney Montgomery Scott LLC acquired a new stake in Rentokil Initial during the 4th quarter worth about $257,000. Finally, Pacifica Capital Investments LLC purchased a new stake in Rentokil Initial during the fourth quarter valued at about $4,894,000. Institutional investors and hedge funds own 9.91% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Sanford C. Bernstein downgraded shares of Rentokil Initial from a "market perform" rating to an "underperform" rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Rentokil Initial in a research note on Friday, March 7th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy".

Get Our Latest Analysis on Rentokil Initial

Rentokil Initial Stock Up 1.1%

NYSE:RTO traded up $0.26 during trading hours on Thursday, hitting $23.35. 591,973 shares of the company's stock traded hands, compared to its average volume of 781,247. The stock's fifty day moving average price is $22.45 and its two-hundred day moving average price is $24.35. The firm has a market cap of $11.79 billion, a P/E ratio of 15.46, a P/E/G ratio of 7.95 and a beta of 0.96. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04. Rentokil Initial plc has a twelve month low of $19.60 and a twelve month high of $34.07.

Rentokil Initial Dividend Announcement

The business also recently declared a semi-annual dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 4th will be given a $0.3825 dividend. This represents a dividend yield of 2.4%. The ex-dividend date is Friday, April 4th. Rentokil Initial's dividend payout ratio (DPR) is 43.71%.

Rentokil Initial Company Profile

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

See Also

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines